A detailed history of Ajo Vista, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Ajo Vista, LLC holds 33,121 shares of CTMX stock, worth $36,101. This represents 0.17% of its overall portfolio holdings.

Number of Shares
33,121
Holding current value
$36,101
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.12 - $1.51 $37,095 - $50,012
33,121 New
33,121 $39,000

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $71.9M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Ajo Vista, LLC Portfolio

Follow Ajo Vista, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ajo Vista, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ajo Vista, LLC with notifications on news.